The Use of Rituximab with Immune Tolerance Induction Therapy for Hemophilia A with Inhibitors
Author:
Affiliation:
1. Department of Pediatrics, Kyung Hee University Hospital at Gangdong, Seoul, Korea
Funder
Korea Hemophilia Foundation
Publisher
The Korean Society of Pediatric Hematology-Oncology
Subject
General Materials Science
Link
http://pdf.medrang.co.kr/CPHO/2015/022/CPHO-022-01-10.pdf
Reference16 articles.
1. Immune Tolerance for the Treatment of Factor VIII Inhibitors - Twenty Years' ‘Bonn Protocol’
2. Induction of Immune Tolerance in Patients with Hemophilia and Antibodies to Factor VIII by Combined Treatment with Intravenous IgG, Cyclophosphamide, and Factor VIII
3. High-potency Antihæmophilic Factor Concentrate prepared from Cryoglobulin Precipitate
4. Rituximab in the treatment of alloimmune factor VIII and IX antibodies in two children with severe haemophilia
5. Rituximab as a single agent in the management of adult patients with haemophilia A and inhibitors: marked reduction in inhibitor level and clinical improvement in bleeding but failure to eradicate the inhibitor
Cited by 2 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. A close insight to factor VIII inhibitor in the congenital hemophilia A;Expert Review of Hematology;2016-08-16
2. Immune tolerance induction in patients with severe hemophilia A with inhibitors;Blood Research;2015
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3